FDA 483 - Eli L. Diamond, MD - August 12, 2022

Eli L. Diamond, MD, a clinical investigator in New York, NY, was inspected by the FDA. The inspection revealed significant data integrity issues related to the preparation and maintenance of accurate case histories. Specifically, efficacy data from source forms were inaccurately transcribed into clinical databases and case report forms for multiple subjects, leading to incorrect efficacy outcomes.